Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
在Delta和Omicron变异株占主导地位期间,mRNA疫苗对成人COVID-19相关急诊就诊、紧急护理和住院治疗的2剂和3剂疫苗效力逐渐减弱——VISION网络,10个州,2021年8月至2022年1月
期刊:Mmwr-Morbidity and Mortality Weekly Report
影响因子:17.3
doi:10.15585/mmwr.mm7107e2
Ferdinands, Jill M; Rao, Suchitra; Dixon, Brian E; Mitchell, Patrick K; DeSilva, Malini B; Irving, Stephanie A; Lewis, Ned; Natarajan, Karthik; Stenehjem, Edward; Grannis, Shaun J; Han, Jungmi; McEvoy, Charlene; Ong, Toan C; Naleway, Allison L; Reese, Sarah E; Embi, Peter J; Dascomb, Kristin; Klein, Nicola P; Griggs, Eric P; Konatham, Deepika; Kharbanda, Anupam B; Yang, Duck-Hye; Fadel, William F; Grisel, Nancy; Goddard, Kristin; Patel, Palak; Liao, I-Chia; Birch, Rebecca; Valvi, Nimish R; Reynolds, Sue; Arndorfer, Julie; Zerbo, Ousseny; Dickerson, Monica; Murthy, Kempapura; Williams, Jeremiah; Bozio, Catherine H; Blanton, Lenee; Verani, Jennifer R; Schrag, Stephanie J; Dalton, Alexandra F; Wondimu, Mehiret H; Link-Gelles, Ruth; Azziz-Baumgartner, Eduardo; Barron, Michelle A; Gaglani, Manjusha; Thompson, Mark G; Fireman, Bruce